Steve Mandel's MDLN Position Overview
Steve Mandel (via Lone Pine Capital LLC) currently holds 11.72 M shares of Medline Inc. (MDLN) worth $492.1 M, representing 3.62% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steve Mandel has initiated a new position in MDLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steve Mandel's Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Steve Mandel
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +11.72 M | New Buy | 11.72 M | $42.00 |
Steve Mandel's Medline Investment FAQs
Steve Mandel first purchased Medline Inc. (MDLN) in Q4 2025, acquiring 11,716,697 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steve Mandel has held Medline Inc. (MDLN) for 1 quarters since Q4 2025.
Steve Mandel's largest addition to Medline Inc. (MDLN) was in Q4 2025, adding 11,716,697 shares worth $492.1 M.
According to the latest 13F filing for Q4 2025, Steve Mandel's firm, Lone Pine Capital LLC, owns 11,716,697 shares of Medline Inc. (MDLN), valued at approximately $492.1 M.
As of the Q4 2025 filing, Medline Inc. (MDLN) represents approximately 3.62% of Steve Mandel's publicly disclosed stock portfolio, making it one of their key holdings.
Steve Mandel's peak holding in Medline Inc. (MDLN) was 11,716,697 shares, as reported at the end of Q4 2025.